221 related articles for article (PubMed ID: 21868363)
1. Tumor progression locus 2 mediates signal-induced increases in cytoplasmic calcium and cell migration.
Hatziapostolou M; Koukos G; Polytarchou C; Kottakis F; Serebrennikova O; Kuliopulos A; Tsichlis PN
Sci Signal; 2011 Aug; 4(187):ra55. PubMed ID: 21868363
[TBL] [Abstract][Full Text] [Related]
2. Proteinase-activated receptor-1-triggered activation of tumor progression locus-2 promotes actin cytoskeleton reorganization and cell migration.
Hatziapostolou M; Polytarchou C; Panutsopulos D; Covic L; Tsichlis PN
Cancer Res; 2008 Mar; 68(6):1851-61. PubMed ID: 18339866
[TBL] [Abstract][Full Text] [Related]
3. Tumor progression locus 2/Cot is required for activation of extracellular regulated kinase in liver injury and toll-like receptor-induced TIMP-1 gene transcription in hepatic stellate cells in mice.
Perugorria MJ; Murphy LB; Fullard N; Chakraborty JB; Vyrla D; Wilson CL; Oakley F; Mann J; Mann DA
Hepatology; 2013 Mar; 57(3):1238-49. PubMed ID: 23080298
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages.
Loniewski KJ; Patial S; Parameswaran N
Mol Immunol; 2007 Jul; 44(15):3715-23. PubMed ID: 17507094
[TBL] [Abstract][Full Text] [Related]
5. The kinase TPL2 activates ERK and p38 signaling to promote neutrophilic inflammation.
Senger K; Pham VC; Varfolomeev E; Hackney JA; Corzo CA; Collier J; Lau VWC; Huang Z; Hamidzhadeh K; Caplazi P; Peng I; Setiadi AF; Francis R; Paler-Martinez A; Kwon YC; Ramirez-Carrozzi V; Sun Y; Grigg PW; Roose-Girma M; Jeet S; Barck KH; Pham A; Ota N; Ha C; Stinson J; Guillory J; Tam L; Modrusan Z; Emson C; McKenzie BS; Townsend MJ; Carano RAD; Warming S; Vucic D; DeVoss J; Lee WP; Lill JR; Zarrin AA
Sci Signal; 2017 Apr; 10(475):. PubMed ID: 28420753
[TBL] [Abstract][Full Text] [Related]
6. Tumor progression locus 2-dependent oxidative burst drives phosphorylation of extracellular signal-regulated kinase during TLR3 and 9 signaling.
Kuriakose T; Rada B; Watford WT
J Biol Chem; 2014 Dec; 289(52):36089-100. PubMed ID: 25378393
[TBL] [Abstract][Full Text] [Related]
7. Tpl2 kinase is upregulated in adipose tissue in obesity and may mediate interleukin-1beta and tumor necrosis factor-{alpha} effects on extracellular signal-regulated kinase activation and lipolysis.
Jager J; Grémeaux T; Gonzalez T; Bonnafous S; Debard C; Laville M; Vidal H; Tran A; Gual P; Le Marchand-Brustel Y; Cormont M; Tanti JF
Diabetes; 2010 Jan; 59(1):61-70. PubMed ID: 19808894
[TBL] [Abstract][Full Text] [Related]
8. The tyrosine kinase Syk regulates TPL2 activation signals.
Eliopoulos AG; Das S; Tsichlis PN
J Biol Chem; 2006 Jan; 281(3):1371-80. PubMed ID: 16291755
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
[TBL] [Abstract][Full Text] [Related]
10. Tpl2 (tumor progression locus 2) phosphorylation at Thr290 is induced by lipopolysaccharide via an Ikappa-B Kinase-beta-dependent pathway and is required for Tpl2 activation by external signals.
Cho J; Melnick M; Solidakis GP; Tsichlis PN
J Biol Chem; 2005 May; 280(21):20442-8. PubMed ID: 15778223
[TBL] [Abstract][Full Text] [Related]
11. IRAK1-independent pathways required for the interleukin-1-stimulated activation of the Tpl2 catalytic subunit and its dissociation from ABIN2.
Handoyo H; Stafford MJ; McManus E; Baltzis D; Peggie M; Cohen P
Biochem J; 2009 Oct; 424(1):109-18. PubMed ID: 19754427
[TBL] [Abstract][Full Text] [Related]
12. Cell adhesion tunes inflammatory TPL2 kinase signal transduction.
Vougioukalaki M; Georgila K; Athanasiadis EI; Eliopoulos AG
Cell Mol Life Sci; 2022 Feb; 79(3):156. PubMed ID: 35218437
[TBL] [Abstract][Full Text] [Related]
13. Tpl2 is a key mediator of arsenite-induced signal transduction.
Lee KM; Lee KW; Bode AM; Lee HJ; Dong Z
Cancer Res; 2009 Oct; 69(20):8043-9. PubMed ID: 19808956
[TBL] [Abstract][Full Text] [Related]
14. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
Kaufmann R; Rahn S; Pollrich K; Hertel J; Dittmar Y; Hommann M; Henklein P; Biskup C; Westermann M; Hollenberg MD; Settmacher U
J Cell Physiol; 2007 Jun; 211(3):699-707. PubMed ID: 17323377
[TBL] [Abstract][Full Text] [Related]
15. Stromal Cell-Derived Factor-1α Promotes Endothelial Colony-Forming Cell Migration Through the Ca
Zuccolo E; Di Buduo C; Lodola F; Orecchioni S; Scarpellino G; Kheder DA; Poletto V; Guerra G; Bertolini F; Balduini A; Rosti V; Moccia F
Stem Cells Dev; 2018 Jan; 27(1):23-34. PubMed ID: 29121817
[TBL] [Abstract][Full Text] [Related]
16. Advancement in TPL2-regulated innate immune response.
Yan MH; Hao JH; Zhang XG; Shen CC; Zhang DJ; Zhang KS; Zheng HX; Liu XT
Immunobiology; 2019 May; 224(3):383-387. PubMed ID: 30853309
[TBL] [Abstract][Full Text] [Related]
17. Tpl2 kinase regulates FcγR signaling and immune thrombocytopenia in mice.
Kyrmizi I; Ioannou M; Hatziapostolou M; Tsichlis PN; Boumpas DT; Tassiulas I
J Leukoc Biol; 2013 Oct; 94(4):751-7. PubMed ID: 23898046
[TBL] [Abstract][Full Text] [Related]
18. Sterile inflammation in acetaminophen-induced liver injury is mediated by Cot/tpl2.
Sanz-Garcia C; Ferrer-Mayorga G; González-Rodríguez Á; Valverde AM; Martín-Duce A; Velasco-Martín JP; Regadera J; Fernández M; Alemany S
J Biol Chem; 2013 May; 288(21):15342-51. PubMed ID: 23572518
[TBL] [Abstract][Full Text] [Related]
19. Tumor progression locus 2 (Tpl2) kinase promotes chemokine receptor expression and macrophage migration during acute inflammation.
Rowley SM; Kuriakose T; Dockery LM; Tran-Nguyen T; Gingerich AD; Wei L; Watford WT
J Biol Chem; 2014 May; 289(22):15788-97. PubMed ID: 24713702
[TBL] [Abstract][Full Text] [Related]
20. Tpl2 and ERK transduce antiproliferative T cell receptor signals and inhibit transformation of chronically stimulated T cells.
Tsatsanis C; Vaporidi K; Zacharioudaki V; Androulidaki A; Sykulev Y; Margioris AN; Tsichlis PN
Proc Natl Acad Sci U S A; 2008 Feb; 105(8):2987-92. PubMed ID: 18287049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
